← Evidence map

ArticleInflammation2019

Pharmacological Evaluation of TAK-828F, a Novel Orally Available RORγt Inverse Agonist, on Murine Colitis Model.

Keiko Igaki et al.PubMed ↗Publisher ↗

No numbers read from the abstract.

9 papers cite it

2019
2020
2021
2022
2023
2024
2025
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 30121880